Literature DB >> 32410092

Genetic variation in the cag pathogenicity island of Helicobacter pylori strains detected from gastroduodenal patients in Thailand.

Wongwarut Boonyanugomol1, Worrarat Kongkasame2, Prasit Palittapongarnpim3, Seung-Chul Baik4, Myung-Hwan Jung4, Min-Kyoung Shin4, Hyung-Lyun Kang4, Woo-Kon Lee4.   

Abstract

There is a lack of evidence of genetic variation in the Helicobacter pylori cag-PAI in Thailand, a region with the low incidence of gastric cancer. To clarify this issue, variation in the H. pylori cag-PAI in strains detected in Thailand was characterized and simultaneously compared with strains isolated from a high-risk population in Korea. The presence of ten gene clusters within cag-PAI (cagA, cagE, cagG, cagH, cagL, cagM, cagT, orf13, virB11, and orf10) and IS605 was characterized in H. pylori strains detected from these two countries. The cagA genotypes and EPIYA motifs were analyzed by DNA sequencing. The overall proportion of the ten cag-PAI genes that were detected ranged between 66 and 79%; additionally, approximately 48% of the strains from Thai patients contained an intact cag-PAI structure, while a significantly higher proportion (80%) of the strains from Korean patients had an intact cag-PAI. A significantly higher proportion of IS605 was detected in strains from Thai patients (55%). Analysis of cagA genotypes and EPIYA motifs revealed a higher frequency of Western-type cagA in Thai patients (87%) relative to Korean patients (8%) who were predominately associated with the East Asian-type cagA (92%). Variations in the Western-type cagA in the Thai population, such as EPIYA-BC patterns and EPIYA-like sequences (EPIYT), were mainly detected as compared with the Korean population (p < 0.05). In summary, H. pylori strains that colonize the Thai population tend to be associated with low virulence due to distinctive cag-PAI variation, which may partially explain the Asian paradox phenomenon in Thailand.

Entities:  

Keywords:  EPIYA motifs; Helicobacter pylori; IS605; Thailand; cag pathogenicity island

Mesh:

Substances:

Year:  2020        PMID: 32410092      PMCID: PMC7455669          DOI: 10.1007/s42770-020-00292-3

Source DB:  PubMed          Journal:  Braz J Microbiol        ISSN: 1517-8382            Impact factor:   2.476


  47 in total

1.  cag, a pathogenicity island of Helicobacter pylori, encodes type I-specific and disease-associated virulence factors.

Authors:  S Censini; C Lange; Z Xiang; J E Crabtree; P Ghiara; M Borodovsky; R Rappuoli; A Covacci
Journal:  Proc Natl Acad Sci U S A       Date:  1996-12-10       Impact factor: 11.205

2.  Clinical relevance of cagPAI intactness in Helicobacter pylori isolates from Vietnam.

Authors:  L T Nguyen; T Uchida; Y Tsukamoto; T D Trinh; L Ta; H B Mai; H S Le; D Q D Ho; H H Hoang; T Matsuhisa; T Okimoto; M Kodama; K Murakami; T Fujioka; Y Yamaoka; M Moriyama
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2010-04-07       Impact factor: 3.267

3.  Analysis of the cag pathogenicity island and IS605 of Helicobacter pylori strains isolated from patients with gastric cancer in Japan.

Authors:  R Deguchi; M Igarashi; K Watanabe; A Takagi
Journal:  Aliment Pharmacol Ther       Date:  2004-07       Impact factor: 8.171

4.  Pediatric Helicobacter pylori isolates display distinct gene coding capacities and virulence gene marker profiles.

Authors:  Sarah Talarico; Benjamin D Gold; Jutta Fero; Dexter T Thompson; Jeannette Guarner; Steven Czinn; Nina R Salama
Journal:  J Clin Microbiol       Date:  2009-04-22       Impact factor: 5.948

5.  Analysis of the vacA, cagA, cagE, iceA, and babA2 genes in Helicobacter pylori from sixty-one pediatric patients from the Midwestern United States.

Authors:  Raymond P Podzorski; Diane S Podzorski; Ann Wuerth; Vasundhara Tolia
Journal:  Diagn Microbiol Infect Dis       Date:  2003-06       Impact factor: 2.803

Review 6.  Tyrosine-phosphorylated bacterial proteins: Trojan horses for the host cell.

Authors:  A Covacci; R Rappuoli
Journal:  J Exp Med       Date:  2000-02-21       Impact factor: 14.307

7.  Helicobacter pylori Type IV Secretion System and Its Adhesin Subunit, CagL, Mediate Potent Inflammatory Responses in Primary Human Endothelial Cells.

Authors:  Mona Tafreshi; Jyeswei Guan; Rebecca J Gorrell; Nicole Chew; Yue Xin; Virginie Deswaerte; Manfred Rohde; Roger J Daly; Richard M Peek; Brendan J Jenkins; Elizabeth M Davies; Terry Kwok
Journal:  Front Cell Infect Microbiol       Date:  2018-02-06       Impact factor: 5.293

8.  The analysis of virulence factors and antibiotic resistance between Helicobacter pylori strains isolated from gastric antrum and body.

Authors:  Ji Won Seo; Jae Yong Park; Tae-Seop Shin; Jae Gyu Kim
Journal:  BMC Gastroenterol       Date:  2019-08-07       Impact factor: 3.067

9.  Helicobacter pylori cagA gene variants in Malaysians of different ethnicity.

Authors:  Ramelah Mohamed; Alfizah Hanafiah; Isa M Rose; Mohd Rizal A Manaf; Shiekh Anwar Abdullah; Ismail Sagap; A van Belkum; Jasmi A Yaacob
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2009-02-27       Impact factor: 3.267

10.  Association of IS605 and cag-PAI of Helicobacter pylori Isolated from Patients with Gastrointestinal Diseases in Taiwan.

Authors:  Chih-Ho Lai; Chin-Lin Perng; Keng-Hsin Lan; Hwai-Jeng Lin
Journal:  Gastroenterol Res Pract       Date:  2013-02-17       Impact factor: 2.260

View more
  2 in total

1.  H. pylori Infection and Virulence Factors cagA and vacA (s and m Regions) in Gastric Adenocarcinoma from Pará State, Brazil.

Authors:  Igor Brasil-Costa; Cintya de Oliveira Souza; Leni Célia Reis Monteiro; Maria Elisabete Silva Santos; Edivaldo Herculano Correa De Oliveira; Rommel Mario Rodriguez Burbano
Journal:  Pathogens       Date:  2022-03-29

2.  Associations between seroprevalence of Helicobacter pylori and ABO/rhesus blood group antigens in healthy blood donors in southwest Iran.

Authors:  Azar Dokht Khosravi; Mehrandokht Sirous; Morteza Saki; Sakineh Seyed-Mohammadi; Seyed Reza Modares Mousavi; Hojat Veisi; Asma Abbasinezhad Poor
Journal:  J Int Med Res       Date:  2021-12       Impact factor: 1.671

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.